logo
Why Fiverr (FVRR) Shares Are Getting Obliterated Today

Why Fiverr (FVRR) Shares Are Getting Obliterated Today

Yahoo2 days ago
What Happened?
Shares of online freelance marketplace Fiverr (NYSE:FVRR) fell 11.8% in the morning session after the company reported second-quarter results that revealed a significant drop in active buyers and provided a weaker-than-expected outlook.
Although the online freelance marketplace surpassed revenue expectations for the quarter, investors focused on more concerning trends. The number of active buyers, a key indicator of platform health, fell by 10.9% compared to the same period last year, dropping to 3.4 million. This decline in users overshadowed a 9.8% increase in spending per buyer. Furthermore, the company's guidance for the upcoming third quarter and its full-year EBITDA forecast both came in below analysts' projections. The combination of a shrinking user base and a cautious outlook for future earnings appeared to raise concerns about the company's growth trajectory.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Fiverr? Access our full analysis report here, it's free.
What Is The Market Telling Us
Fiverr's shares are very volatile and have had 21 moves greater than 5% over the last year. But moves this big are rare even for Fiverr and indicate this news significantly impacted the market's perception of the business.
The biggest move we wrote about over the last year was 9 months ago when the stock gained 24.3% on the news that the company reported a "beat and raise" quarter. Third-quarter earnings beat analysts' revenue, EBITDA, and EPS expectations. Efforts to improve value-added services paid off as take rate improved and the average spend per buyer rose 9% from the prior year. Notably, Fiverr introduced an AI-powered matching tool for buyers with complex job requirements. As a result, the number of buyers spending over $10K on Fiverr also increased. Given these improvements, the company was able to comfortably raise full-year revenue and EBITDA guidance, which put the business on track to meet and perhaps exceed the three-year targets on Adjusted EBITDA and free cash flow provided in the previous quarter. Holding aside expectations, its number of buyers declined, which is a negative. Overall, though, this quarter was solid.
Fiverr is down 30.9% since the beginning of the year, and at $22.13 per share, it is trading 37.6% below its 52-week high of $35.45 from December 2024. Investors who bought $1,000 worth of Fiverr's shares 5 years ago would now be looking at an investment worth $241.68.
Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NVO: Novo Nordisk Stock Climbs After Major FDA Approval
NVO: Novo Nordisk Stock Climbs After Major FDA Approval

Yahoo

time33 minutes ago

  • Yahoo

NVO: Novo Nordisk Stock Climbs After Major FDA Approval

Aug 1 - Novo Nordisk (NYSE:NVO) gained nearly 3% in Friday morning trading after the company secured expanded U.S. approval for its Alhemo injection. The therapy can now help prevent or reduce bleeding episodes in adults and children 12 and older with hemophilia A or B. Warning! GuruFocus has detected 1 Warning Sign with NVO. Previously, Alhemo was only authorized for patients with hemophilia A or B who developed inhibitors. The new decision from the U.S. Food and Drug Administration followed a late?stage clinical trial that demonstrated the drug's safety and ability to lower bleeding risk in a broader patient group. Analysts say this approval could significantly expand Alhemo's market potential. The hemophilia space is becoming increasingly competitive with gene therapies and new clotting factor treatments, but Novo Nordisk's broader label should reinforce its rare disease portfolio. The company expects Alhemo to contribute to revenue growth in the second half of 2025 as more patients gain access. Investors will watch whether this momentum continues into upcoming quarters as the therapy reaches a larger base of hemophilia patients. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Lazard Announces Total Consideration for Lazard Group LLC's Cash Tender Offer for Its 3.625% Senior Notes Due 2027
Lazard Announces Total Consideration for Lazard Group LLC's Cash Tender Offer for Its 3.625% Senior Notes Due 2027

Business Wire

time34 minutes ago

  • Business Wire

Lazard Announces Total Consideration for Lazard Group LLC's Cash Tender Offer for Its 3.625% Senior Notes Due 2027

NEW YORK--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) announced today the Total Consideration as set forth in the table below in respect of the previously announced cash tender offer (the 'Tender Offer') of its subsidiary Lazard Group LLC ('Lazard Group') for any and all of its outstanding 3.625% Senior Notes due March 1, 2027 (the 'Notes'). The Tender Offer is being made upon the terms and conditions in the Offer to Purchase dated July 28, 2025. The Tender Offer will expire today at 5:00 p.m. (New York City time), unless extended or terminated as described in the Offer to Purchase (such time and date, as they may be extended, the 'Expiration Time'). Holders of the Notes are urged to carefully read the Offer to Purchase and Notice of Guaranteed Delivery before making any decision with respect to the Tender Offer. As previously announced, in order to be eligible to receive the 'Total Consideration,' holders must (i) validly tender their Notes on or prior to the Expiration Time or (ii) deliver a properly completed Notice of Guaranteed Delivery and all other required documents at or prior to the Expiration Time and validly tender their Notes at or prior to 5:00 p.m. (New York City time) on the second business day after the Expiration Time pursuant to guaranteed delivery procedures. The Total Consideration for each $1,000 principal amount of Notes validly tendered and not validly withdrawn was determined in the manner described in the Offer to Purchase by reference to the fixed spread over the yield to maturity based on the bid side price of the UST Reference Security listed below, calculated by the Dealer Managers (as defined below) for the Tender Offer as of 2:00 p.m. (New York City time) today, the date on which the Tender Offer is currently scheduled to expire, and is set forth in the table below. In addition to the Total Consideration, accrued and unpaid interest up to, but not including, the Settlement Date (as defined below) will be payable in cash on all validly tendered and accepted Notes. Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures. As a result, Notes tendered through the guaranteed delivery procedures will not receive accrued interest from the Settlement Date through the Guaranteed Delivery Settlement Date (as defined below), which is expected to be two business days after the Settlement Date. Payment for Notes validly tendered in the Tender Offer and accepted by Lazard Group for purchase will be made on the date referred to as the 'Settlement Date' or, in the case of Notes tendered through guaranteed delivery procedures, the 'Guaranteed Delivery Settlement Date.' The Settlement Date is expected to occur on the next business day following the Expiration Time, and the Guaranteed Delivery Settlement Date is currently expected to occur on the third business day following the Expiration Time. The closing of the Tender Offer is subject to the satisfaction or waiver of certain conditions as set forth in the Offer to Purchase. Lazard Group reserves the right, subject to applicable law, to (i) waive any and all conditions to the Tender Offer, (ii) extend the Expiration Time, (iii) amend the Tender Offer in any respect (including, without limitation, to change the fixed spread), or (iv) terminate the Tender Offer on or prior to the Expiration Time and return the Notes tendered pursuant thereto, in each case by giving written or oral notice of such extension, amendment, or termination to Global Bondholder Services Corporation, the tender agent (in such capacity, the 'Tender Agent'). This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell the Notes. The Tender Offer is being made solely by means of the Offer to Purchase and Notice of Guaranteed Delivery dated July 28, 2025. The Tender Offer is void in all jurisdictions where it is prohibited. In those jurisdictions where the securities, blue sky, or other laws require the Tender Offer to be made by a licensed broker or dealer, the Tender Offer will be deemed to be made on behalf of Lazard Group by the Dealer Managers or one or more registered brokers or dealers licensed under the laws of such jurisdictions. Citigroup Global Markets Inc. is acting as the lead dealer manager and Lazard Frères & Co. LLC is acting as co-dealer manager (together, the 'Dealer Managers') for the Tender Offer. Requests for documents may be directed to Global Bondholder Services Corporation, the information agent (in such capacity, the 'Information Agent'), by telephone at (212) 430-3774, in writing at Attn: Corporate Actions, 65 Broadway—Suite 404, New York, New York 10006 or by email at contact@ Copies of the Offer Documents are also available at the following website: Questions regarding the Tender Offer may be directed to Citigroup Global Markets Inc. by telephone at (800) 558-3745 (toll-free) or (212) 723-6106 (collect) or in writing at Attn: Liability Management Group, 388 Greenwich Street, Trading 4th Floor, New York, New York 10013. None of Lazard Group or its affiliates, their respective boards of directors, the Dealer Managers, the Tender Agent, the Information Agent or the trustee for the Notes makes any recommendation as to whether holders should tender any of their Notes. Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amount of their Notes to tender. About Lazard Founded in 1848, Lazard is one of the world's preeminent financial advisory and asset management firms, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by the use of forward-looking terminology such as 'may,' 'might,' 'will,' 'should,' 'could,' 'would,' 'expect,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'potential,' 'target,' 'goal,' 'pipeline,' or 'continue,' and the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies, business plans and initiatives and anticipated trends in our business. These forward-looking statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. These factors include, but are not limited to, those discussed in our Annual Report on Form 10-K under Item 1A 'Risk Factors,' and also discussed from time to time in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including the following: Adverse general economic conditions or adverse conditions in global or regional financial markets; Changes in international trade policies and practices, including the implementation of tariffs, proposed further tariffs, and responses from other jurisdictions, and the economic impacts, volatility and uncertainty resulting therefrom; A decline in our revenues, for example due to a decline in overall mergers and acquisitions ('M&A') activity, our share of the M&A market or our assets under management ('AUM'); Losses caused by financial or other problems experienced by third parties; Losses due to unidentified or unanticipated risks; A lack of liquidity, i.e., ready access to funds, for use in our businesses; Competitive pressure on our businesses and on our ability to retain and attract employees at current compensation levels; and Changes in relevant tax laws, regulations or treaties or an adverse interpretation of those items. These risks and uncertainties are not exhaustive. Our SEC reports describe additional factors that could adversely affect our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. As a result, there can be no assurance that the forward-looking statements included in this release will prove to be accurate or correct. Although we believe the statements reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, achievements or events. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this release to conform our prior statements to actual results or revised expectations and we do not intend to do so. Lazard, Inc. is committed to providing timely and accurate information to the investing public, consistent with our legal and regulatory obligations. To that end, Lazard and its operating companies use their websites, and other social media sites to convey information about their businesses, including the anticipated release of quarterly financial results, quarterly financial, statistical and business-related information, and the posting of updates of AUM in various mutual funds, hedge funds and other investment products managed by Lazard Asset Management LLC and Lazard Frères Gestion SAS.

NVIDIA Corporation (NVDA) Could Be In Great Shape In China, Says Jim Cramer
NVIDIA Corporation (NVDA) Could Be In Great Shape In China, Says Jim Cramer

Yahoo

time38 minutes ago

  • Yahoo

NVIDIA Corporation (NVDA) Could Be In Great Shape In China, Says Jim Cramer

We recently published . NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks Jim Cramer recently discussed. NVIDIA Corporation (NASDAQ:NVDA) has started to become a regular feature on Cramer's morning show as it solidifies its position as the world's most valuable company. In his earlier remarks about the firm, the CNBC TV host has praised the firm's CEO, Jensen Huang, and his success in convincing the Trump administration to lift GPU sales restrictions on China. Once the restrictions were lifted, the market started speculating whether NVIDIA Corporation (NASDAQ:NVDA) could meet Chinese demand. Cramer discussed this issue in the context of EDA provider Cadence's recent results: 'By the way, Cadence, that is, when people look at Cadence, the number one partner is NVIDIA. Now NVIDIA also has the story out there, but not confirmed by me, that there's, the H20 orders from China are huge. There had been some talk that maybe they wouldn't be. Cadence is a fantastic company. And I think that that was the sign that NVIDIA is in great shape in China. NVIDIA's doing so well, what are you going to do? It just keeps, it's just relentless.' Here's what he said earlier about NVIDIA Corporation (NASDAQ:NVDA): 'Okay, I'm getting a lot of pushback for my like of Jensen Huang, saying he's really a globalist. It's not what we want. I'm saying, if everything is based on his chips, we are a new kind of reserve currency. And it's kind of exciting. . .new semiconductor, it's another thing that we're great at. That's Jensen. And Jensen, see a lot of this is what it's written on, what are they going to build on. . .and if you have to write on NVIDIA, David, instead of Huawei, the Chinese could end up being the pitiful, helpless giant.' While we acknowledge the potential of NVDA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store